title: Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
abstract: Monocyte transformation by the v-myc oncogene has been used to study myelomonocytic tumor progression in vitro. Murine monocytes transformed by a recombinant retrovirus containing MC29 v-myc were found to exhibit a proliferative burst to day 28-40 post-infection. There-after growth slowed and cell number remained relatively static to day 80-90 post-infection. During both the proliferative and quiescent periods, the cells were dependent on the myelomonocytic growth factor CSF-1 for growth and viability. Analysis of this transformation revealed that the initial transformants were polyclonal, non-immortal, and non-tumorigenic in syngeneic mice. At day 80-90 post infection, a fresh round of cellular proliferation occurred and, in contrast to the initial burst, growth was sustained allowing the establishment of cell lines. These lines were found to be monoclonal, immortal, growth factor independent and, in certain cases, tumorigenic in syngeneic mice. Associated with the establishment of growth factor independent cell lines was the constitutive synthesis of the myelomonocytic growth factor, CSF-1. Proto-oncogene screening of the initial transformants and the cell lines also revealed the expression of c-raf and the CSF-1 receptor, c-fms. Our results indicate that, following transformation by v-myc, monocytes can progress in vitro to become growth factor independent and immortal and that both monocyte transformation and immortalization can be dissociated from tumorigenicity.
authors.affiliation: Leukaemia Research and Viral Pathology Unit, Children's Medical Research Foundation, Camperdown, Sydney, NSW, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Stapleton
authors.forename: Y
authors.initials: Y
authors.lastname: Takayama
authors.forename: A
authors.initials: A
authors.lastname: Hartshorn
authors.forename: A
authors.initials: A
authors.lastname: Kalaizis
authors.forename: P B
authors.initials: PB
authors.lastname: Rowe
authors.forename: G
authors.initials: G
authors.lastname: Symonds
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D004622:Embryo, Mammalian; D016259:Genes, myc; D007621:Karyotyping; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D009000:Monocytes / Q000166:cytology; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000235:genetics / Q000473:pathology; D011519:Proto-Oncogenes; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D012190:Retroviridae / Q000235:genetics; D014162:Transfection
chemical_list: D012313:RNA; D016173:Macrophage Colony-Stimulating Factor; D004247:DNA